Last Updated on Jul 04, 2018

Latest Publications and Research on Cardiac Markers

Life Sci.  2020 Jan 30  

Circulating follicular T helper cells and humoral reactivity in rheumatic heart disease.

Liu Z, Wang Y, Li F, Liu M, Shi J, Dong N

This study aimed to profile circulating T follicular helper cells (cTfh) and their effect on B cells in rheumatic heart disease (RHD).... Read More

Source: PubMed


J. Alzheimers Dis.  2020 Jan 28  

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.

Jääskeläinen O, Hall A, Tiainen M, van Gils M, Lötjönen J, Kangas AJ, Helisalmi S, Pikkarainen M, Hallikainen M, Koivisto A, Hartikainen P, Hiltunen M, Ala-Korpela M, Soininen P, Soininen H, Herukka SK

Accurate differentiation between neurodegenerative diseases is developing quickly and has reached an effective level in disease recognition. However, ... Read More

Source: PubMed

J. Nutr. Biochem.    

Cow's milk polar lipids reduce atherogenic lipoprotein cholesterol, modulate gut microbiota and attenuate atherosclerosis development in LDL-receptor knockout mice fed a Western-type diet.

Millar CL, Jiang C, Norris GH, Garcia C, Seibel S, Anto L, Lee JY, Blesso CN

Milk sphingomyelin (SM), a polar lipid (PL) component of milk fat globule membranes, is protective against dyslipidemia. However, it is unclear whethe... Read More

Source: PubMed

Clin. Biochem.  2020 Jan 30  

Current immunoassay methods and their applications to clinically used biomarkers of breast cancer.

Jeong S, Park MJ, Song W, Kim HS

Breast cancer is the leading cause of cancer-related mortality worldwide, with a higher incidence in developed countries. The biomarkers for breast ca... Read More

Source: PubMed

Chem. Biol. Interact.  2020 Jan 30  

Rosuvastatin and retinoic acid may act as 'pleiotropic agents' against ß-adrenergic agonist-induced acute myocardial injury through modulation of multiple signalling pathways.

Sultan F, Kaur R, Mir AH, Maqbool I, Lonare M, Singh D, Rampal S, Dar JA

Cardiovascular disorders constitute the principal cause of deaths worldwide and will continue as the major disease-burden by the year 2060. A signific... Read More

Source: PubMed

Comments

Randox Monday, November 15, 2010

The ischemic biomarker Heart-type Fatty Acid Binding Protein [H-FABP] can substantially improve the detection of high risk patients when Troponin-negative, even when a high sensitivity assay is used, a new publication has shown. In the June edition of JACC, Professor Alistair Hall and colleagues from the University of Leeds, UK, prospectively studied a cohort of 1080 consecutive patients admitted to hospital with suspected ACS and compared the H-FABP assay (Randox Laboratories) with the high sensitivity Ultra-TnI assay (Siemens Healthcare Diagnostics).

Most Popular on Medindia